Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Dermatol ; 24(7): 536-42, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25828729

ABSTRACT

Leprosy is a chronic granulomatous disease caused by Mycobacterium leprae affecting the skin and peripheral nerves. Despite M. leprae invasion of the skin and keratinocytes importance in innate immunity, the interaction of these cells in vitro during M. leprae infection is poorly understood. Conventional and fluorescence optical microscopy, transmission electronic microscopy, flow cytometry and ELISA were used to study the in vitro interaction of M. leprae with the HaCaT human keratinocyte cell line. Keratinocytes uptake of M. leprae is described, and modulation of the surface expression of CD80 and CD209, cathelicidin expression and TNF-α and IL-1ß production of human keratinocytes are compared with dendritic cells and macrophages during M. leprae interaction. This study demonstrated that M. leprae interaction with human keratinocytes enhanced expression of cathelicidin and greatly increased TNF-α production. The highest spontaneous expression of cathelicidin was by dendritic cells which are less susceptible to M. leprae infection. In contrast, keratinocytes displayed low spontaneous cathelicidin expression and were more susceptible to M. leprae infection than dendritic cells. The results show, for the first time, an active role for keratinocytes during infection by irradiated whole cells of M. leprae and the effect of vitamin D on this process. They also suggest that therapies which target cathelicidin modulation may provide novel approaches for treatment of leprosy.


Subject(s)
Keratinocytes/immunology , Keratinocytes/microbiology , Leprosy/immunology , Leprosy/microbiology , Mycobacterium leprae/immunology , Mycobacterium leprae/pathogenicity , Antimicrobial Cationic Peptides/metabolism , B7-1 Antigen/metabolism , Cell Adhesion Molecules/metabolism , Cell Line , Dendritic Cells/immunology , Dendritic Cells/microbiology , Dendritic Cells/pathology , Humans , Immunity, Cellular , Interleukin-1beta/biosynthesis , Keratinocytes/pathology , Lectins, C-Type/metabolism , Leprosy/pathology , Macrophages/immunology , Macrophages/microbiology , Macrophages/pathology , Phagocytosis , Receptors, Cell Surface/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Cathelicidins
2.
Curr Microbiol ; 57(5): 463-8, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18810543

ABSTRACT

Bacterial infections are a significant cause of morbidity and mortality among critically ill patients. The increase of antibiotic resistance in bacteria from human microbiota-such as Staphylococcus epidermidis, an important nosocomial pathogen that affects immunocompromised patients or those with indwelling devices-increased the desire for new antibiotics. In this study we designed, synthesized, and determined the antimicrobial activity of 27 thieno[2,3-b]pyridines (1, 2, 2a-2m, 3, 3a-3m) derivatives against a drug-resistant clinical S. epidermidis strain. In addition, we performed a structure-activity relationship analysis using a molecular modeling approach, and discuss the drug absorption, distribution, metabolism, excretion, and toxicity profile and Lipinski's "rule of five," which are tools to assess the relationship between structures and drug-like properties of active compounds. Our results showed that compound 3b (5-(1H-tetrazol-5-yl)-4-(3;-methylphenylamino)thieno[2,3-b]pyridine) was as active as oxacillin and chloramphenicol but with lower theoretical toxicity risks and a better drug likeness and drug score potential than chloramphenicol. All molecular modeling and biological results reinforced the promising profile of 3b for further experimental investigation and development of new antibacterial drugs.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Drug Design , Drug Resistance, Bacterial , Staphylococcal Infections/drug therapy , Staphylococcus epidermidis/drug effects , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacokinetics , Bacteria/drug effects , Drug Evaluation, Preclinical , Humans , Microbial Sensitivity Tests , Models, Molecular , Pyridines/chemical synthesis , Pyridines/chemistry , Pyridines/pharmacokinetics , Pyridines/pharmacology , Staphylococcal Infections/microbiology , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...